Your browser doesn't support javascript.
loading
United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023.
Booth, M E; Clements, H A; Helbrow, J; Baxter, M A; Bleaney, C W; Hawkins, M A; Markar, S R; Peters, C J; Smyth, E C; Crosby, T D L.
Afiliação
  • Booth ME; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Clements HA; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. Electronic address: hollie.clements1@nhs.net.
  • Helbrow J; South West Wales Cancer Centre, Swansea Bay University Health Board, Swansea, UK.
  • Baxter MA; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
  • Bleaney CW; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, UK.
  • Markar SR; Nuffield Department of Surgical Sciences, University of Oxford, UK.
  • Peters CJ; Department of Surgery and Cancer, Imperial College London, UK.
  • Smyth EC; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.
  • Crosby TDL; Velindre University NHS Trust, Cardiff, UK.
Article em En | MEDLINE | ID: mdl-38876807

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article